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1. Introduction
   The success in elucidation of genome sequences of several 
micro-organisms including Plasmodium falciparum (P. 
falciparum) in the pre-genomic era has challenged research 
for identification of potential proteomic markers correlated 
disease pathology, as well as protein targets of candidate 
drugs and vaccines in the post genomic era. Proteomics 
analysis is the large-scale study of proteins, particularly 
their structures and functions. It determines global protein 
expression including sub-cellular localization and post-
translational modification. The approach is much more 
complicated than the genomics approach due to the fact 
that, while the genome of an organism is relatively stable, 
its proteome differs from cell to cell and from time to time. 
This is because distinct genes are expressed in distinct cell 
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types. Detection of a marked change in the expression of 
proteins that are vital for the survival of a micro-organism 
represents one of the most important strategies in drug 
discovery research. Two-dimensional gel electrophoresis 
(2-DE) is the common technique applied for investigation 
of the change in these expressed proteins. The proteins are 
firstly electrophoresed in one direction, followed by another 
direction which allows for the visualization of a small change 
in protein expression which is finally identified by mass 
spectrometry[1,2]. 
   A large number of medicinal plants have been identified 
as potential antimalarial agents. The antimalarial activity of 
Garcinia mangostana (G. mangostana) Linn. or mangosteen 
has previously been reported with IC50 (concentration which 
inhibits parasite growth by 50%) ranging from 4.5 to 12.6 µg/mL[3,4]. 
Variety of biological activities of xanthones isolated from 
this fruit pericarp has also been reported[5-7]. The aim of the 
present study was to identify protein targets for antimalarial 
activity of G. mangostana Linn. (pericarp) in 3D7 P. 
falciparum clone using 2-DE and liquid chromatography 
mass-spectrometry (LC/MS/MS). 
2. Materials and methods
2.1. Crude extract of G. mangostana Linn. (pericarp), 
chemicals and reagents
   The G. mangostana fruit pericarps were washed, cut into 
small pieces, air-dried, weighed and ground into powder. 
The powder was then soaked in ethanol until exhaustion. 
The ethanol extract was filtrated and evaporated under 
reduced pressure by rotary evaporation. The extract yield 
was weighed and stored at -20 °C until used.
2.2. Assessment of antimalarial activity of crude ethanolic 
extract of G. mangostana Linn. in vitro
   3D7 P. falciparum clone was used in this study. The 
parasite was cultured according to the method of Trager and 
Jensen with some modifications[8]. Antimalarial activity of 
the crude ethanolic extract of G. mangostana Linn. (pericarp) 
was investigated using SYBR Green I assay[9,10]. Highly 
synchronous ring stage parasite was used in each assay. An 
aliquot of parasite inoculum (50 µL) with 2% parasitaemia 
and 1% haematocrit was added into each well of a 96-well 
microtiter plate. The 96-well drug plates were dosed with 
the extract at eight final concentrations as follows: 0.78125, 
1.5625, 3.125, 6.25, 12.5, 25, 50 and 100 µg/mL. The experiment 
was done in triplicate. The IC50 and IC90 values used as 
indicators of antimalarial activity were determined from 
a log-dose–response curve plotted using the CalcusynTM 
version 1.1 (BioSoft, Cambridge, UK).
2.3. Extraction of P. falciparum proteins following exposure 
to the ethanolic extract of G. mangostana Linn.
   Synchronized 3D7 P. falciparum was exposed to the 
ethanolic extract of G. mangostana Linn. at the IC50 and IC90 
for 12 h. Parasite culture was harvested and cell pellet was 
re-suspended in 0.15% saponin and incubated on ice for 
1 h in order to lyse red blood cells. The lysate was collected 
through centrifugation at 8 500 r/min for 5 min (4 °C) and 
washed three times with 1 mL of 50 mmol/L Tris (pH 7.5) 
until the supernatant was clear. The parasite pellet was re-
suspended in 500 µL of rehydration buffer (8 mol/L urea, 2 
mol/L thiourea, 2% CHAPS, 65 mmol/L DL-Dithiothreitol, 1% 
ampholyte (pH 3-10), and 1伊 of protease inhibitor). Sample 
was vortexed and sonicated on ice for four times, six seconds 
each (21% amplitude, 6 seconds, interspersed with 9 seconds), 
followed by centrifugation at 8 500 r/min for 1 h (4 °C). Protein 
concentration was measured using Bradford reagent (BioRad 
Co. Ltd., California, USA) and the supernatant was subjected 
to 2-DE analysis[11,12]. 
2.4. 2-DE 
   The extract of parasite protein (100 µg) was mixed with 
rehydration buffer (8 mol/L urea, 1% CHAP, 15 mmol/L 
dithiothretol, and 0.001% bromophenol blue) to prepare 
125 µL of protein mixture and then applied onto 7 cm 
immobilized pH gradient strips (non-linear) with a pH range 
of 3-10 in an isoelectric focusing (IEF) system (PROTEAN® 
i12™ IEF Cell, BioRad Co. Ltd., California, USA). The IEF 
was initially performed at 250 V for 15 min, followed by 
4 000 V for 1 h and 4 000-20  000 volt-hour. The focused 
strips were equilibrated in equilibration solution I [10 mL 
of 50 mmol/L Tris-HCl pH 8.8, 6 mol/L urea, 30% glycerol, 
and 2% sodium dodecyl sulfonate (SDS)] containing the 
reducing agent DL-Dithiothreitol (100 mg) for 10 min, 
followed by equilibration solution II (5 mL) containing 
iodoacetamide (450 mg) for additional 10 min. Finally, the 
strips were equilibrated with 1伊 electrode buffer (pH 8.3) 
for 10 min. The strips were then loaded onto 12% SDS-
polyacrylamide gel electrophoresis for second dimension 
separation. The gels were run on 1伊 electrode buffer (pH 
8.3). After electrophoresis, gels were fixed and stained with 
silver stain (BioRad Co. Ltd., California, USA) according the 
manufacturer’s recommendation. The 2-DE gel images were 
scanned and analyzed using PDQuestTM software (BioRad Co. 
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Ltd., California, USA). At least four independent gels were 
analyzed for each sample group. 
 
2.5. Identification of proteins 
   Selection of protein spots separated by 2-dimensional 
gels was guided through images on quadruple gels. Briefly, 
the excised gel spot was put into a 1.5 mL centrifuge tube 
and acetonitrile (400 µL) was added. The mixture was 
incubated at room temperature for 10 min. The gel slices 
were then incubated overnight at 37 °C in 10-20 µL of 
sequence grade trypsin (Sigma, Dorset, UK) (10 µg/mL of 25 
mmol/L ammonium bicarbonate with 10% acetonitrile). The 
supernatant was collected through centrifuge at  6 560 r/min 
(4 °C), and the gel was incubated with 20 µL of the mixture 
of acetonitrile and 100 mmol/L ammonium bicarbonate (2:1, 
v/v) at room temperature for 15 min. The supernatant was 
removed and pooled together with the first aliquot. The 
combined supernatant was dried in a rotational vacuum 
concentrator (at 37 °C for 3 h), and the dried samples were 
kept at -80 °C until used.
   The sample was re-suspended in 20 µL of 0.1% formic 
acid and centrifuge at 8 500 r/min (4 °C) for 20 min. Proteins 
were separated using nano-flow high-performance liquid 
chromatography on a C18 reverse phase Dionex Ultimate 
3000 column (Thermo Scientific, California, USA) and the 
mobile phase consisting of 50% acetonitrile for 30 min. 
The elute proteins were detected using LTQ ion-trap mass 
spectrometer (Thermo Scientific, California, USA). The 
resulting MS/MS spectra were submitted to TurboSequest 
Bioworks version 3.1 (Thermo Electron, California, USA) and 
the individual spectrum was merged into an MGF file before 
submitting to Mascot (v2.2).  
3. Results
   The median (range) IC50 and IC90 values of the ethanolic 
extract of G. mangostana Linn. (pericarp) for the 3D7 P. 
falciparum clone were 12.6 (10.5-13.2) and 27.3 (24.7-48.4) µg/
mL, respectively. The patterns of protein spots separated 
from the parasite extract following exposure to 12 (IC50) 
and 30 (IC90) µg/mL of the plant extract including the non-
exposed parasite are shown in Figure 1. The number of 
protein spots from the parasite extract following exposure 
to 12 and 30 µg/mL and the control were 102, 73 and 95, 
respectively. The number of matched protein spots with 
the control for the parasite exposed to the plant extract 
at the concentrations of 12 and 30 µg/mL were 84 (82%) 
and 11 (15%), respectively. Among these matched spots, 
the number of clear up-regulated protein spots (at least 
3 out of 4 spots) were 22 and 11 for the parasite extract 
following exposure to 12 and 30 µg/mL extract, respectively 
(Table 1 and 2). The six protein spots at least two-fold up-
regulated were identified by LC/MS/MS as phosphoglycerate 
mutase putative (PGM1), L-lactate dehydrogenase (LDH)/
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and 
fructose-bisphosphate aldolase/phosphoglycerate kinase 
(PGK) (Table 3). All these proteins were enzymes that play 
role in glycolysis pathway. The proteosome subunit putative 
protein was found only in parasite extract following exposure 
to 30 µg/mL of the plant extract.
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Figure 1. Differential expression of protein spots from the extract of 3D7 
P. falciparum separated by 2-DE: (A) control (non-exposed), (B) following 
exposure to the extract of G. mangostana Linn. (pericarp) at the IC50 level 
(12 µg/mL), and (C) following exposure to the extract of G. mangostana Linn. 
(pericarp) at the IC90 level (30 µg/mL).
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Table 1 
Comparison of 2-DE protein spots from 3D7 P. falciparum exposure 
to G. mangostana Linn. (pericarp) at 12 µg/mL with at least 2-fold 
increase in density compared with control.
Spot ID Protein spot density Ratio of spot density
(exposed/control)
Control Exposed to 12 µg/mL
1102 327228.30 -  0.00
2006   70497.30 -  0.00
2108 308001.80 -  0.00
2211 511576.90 -  0.00
2507 962410.40 -  0.00
5205   72382.30 -  0.00
5309 141748.70 -  0.00
5414 493481.40 -  0.00
7120    6336.00 -  0.00
8109 349470.80 -  0.00
8208 224686.70 -  0.00
8013 118752.20   367943.30  3.10
6005   56925.70   177043.60  3.11
6007   75021.20   236373.40  3.15
8012   69251.20   218654.80  3.16
6112 292829.80 1055952.10  3.61
6205 158713.30   691401.70  4.36
2210 198064.60   897992.90  4.53
5104   85343.10   406396.40  4.76
8106 146820.80   718545.10  4.89
3108 193890.50   955672.50  4.93
7115 175944.10   914203.40  5.20
6307   54313.00   315164.60  5.80
2408   33665.60   203455.10  6.04
7114 126117.20   795175.10  6.31
6204 118583.80   780371.60  6.58
4408 107065.50   876504.40  8.19
7113   74850.90   706481.40  9.44
5412    7313.60     80676.10 11.03
6113  66245.50   749835.30 11.32
7004  86445.00  1323992.80 15.32
4211  32429.70   551161.00 17.00
7204  25699.70   715906.10 27.86
Table 2   
Comparison of 2-DE protein spots from 3D7 P. falciparum exposure 
to G. mangostana Linn. (pericarp) at 30 µg/mL with at least 2-fold 
increase in density compared with control.
Spot ID Protein spot density Ratio of spot density
(exposed/control)Control Exposed to 30 µg/mL
1005   937120.0 1097044.0  1.17
1006   642015.9 1031071.0  1.61
1102 3241389.0   957180.4  0.30
2006 1225975.1   858408.8  0.70
2007    32429.7   638622.9 19.69
2008  902078.9   513838.9   0.57
2009  511576.9   340800.0   0.67
2106  728049.3   306116.8   0.42
2107 1072162.8   258182.8   0.24
2108  308001.8   198814.9   0.65
2109  170356.2   122522.1   0.72
Table 3  
Identification of protein spots (by LC/MS/MS) separated from the extract of 
3D7 P. falciparum following exposure to the extract of G. mangostana Linn. 
(pericarp) at either concentration of IC50 (12 µg/mL) or IC90 (30 µg/mL).
No Spot 
ID
Protein name Accession 
Number
MW 
(kDa)
pI Sequence 
coverage
Score PlasmoDB
1 7004 PGM1 XP_001347879.1 28.8 8.28 12.40 19.03 PF3D7_1120100 
2 7114 LDH XP_001349989 34.1 7.55 27.22 50.84 PF3D7_1324900 
GAPDH XP_001348772.1 36.6 7.69 47.48 36.80 PF3D7_1462800 
3 7115 Fructose-
bisphosphate 
aldolase
XP_001348599.1 40.1 8.12 20.05 26.76 PF3D7_1444800 
PGK XP_001352096.1 45.4 7.83 11.06 26.32 PF3D7_0922500
4 3108 Unknown - - - - - -
5 6005 Unknown - - - - - -
6 6225 Proteasome 
subunit, putative
XP_001350251.1 27.2 6.55 26.97 36.54 PF3D7_1353900
4. Discussion
   The proteomics approach is a potential tool for target 
identification in the discovery of medicines and vaccines. 
For malaria research in the post-genomics era, this tool 
has facilitated the search for new promising targets that are 
selective and biologically significant for parasite’s growth 
and survival. Nevertheless, the application of 2-DE in 
the investigation of malaria parasite proteomes has been 
limited due to the problem relating to the extraction and 
solubilization of parasite proteins. In our previous study, 
the ethanolic extract of G. mangostana Linn. (pericarp) was 
shown to exhibit good to moderate antimalarial activity with 
IC50 of 4.5-12.6 µg/mL[4]. In the present study, the proteomics 
approach was applied to analyze possible malarial parasite’s 
protein targets of G. mangostana Linn. (pericarp). Difference 
in protein patterns of 3D7 P. falciparum extract following 
exposure to the plant extract at the concentrations of 12 (IC50) 
and 30 (IC90) µg/mL was observed. At the IC50 concentration, 
about 82% of the expressed parasite proteins were found to 
be matched with the control, while at the IC90 concentration, 
only 15% matched proteins were found. The possible 
explanation for this phenomenon is that the concentration 
at IC90 level was too high to detect an initial change in 
protein expression. This supposition was supported by 
the detection of proteasome subunit protein expressed 
following parasite’s exposure to the extract at the IC90 level. 
Although malaria parasites critically rely on lysosomes 
and the ubiquitin proteasome system for their growth and 
survival[13,14], this proteasome subunit protein plays a major 
role in the degradation of cellular contents of the damaged 
parasites[13,14]. Following parasite’s exposure to the extract at 
the IC50 level on the other hand, an initial change in protein 
expression was observed, but with absence of this protein. 
The expression of proteins that were markedly changed 
(at least three-fold up-regulated) are proteins which are 
involved in the glycolysis pathway, i.e., PGM1, LDH/GAPDH, 
and fructose-bisphosphate aldolase/PGK[15,16]. The malaria 
parasite utilizes glucose for energy production, which is 
converted to lactate[15]. Several glycolytic intermediates 
may be diverted into other products that serve as precursors 
for the synthesis of other final products, particularly 
those involved in the redox system[16]. In the footprinting 
metabolites, pyruvates were expressed at the level of about 
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six times of the control (Chaijaroenkul et al, unpublished 
data). The metabolism of pyruvate may provide intermediates 
in several biosynthetic pathways. Furthermore, direct 
evidence showed that G. mangostana Linn. (pericarp) might 
affect glucose or glycolysis pathway of malaria parasite. 
   The proteomics approach is a potential tool for target 
identification in the drug discovery. Investigation of possible 
protein targets for antimalarial activity of ethanolic extract of 
G. mangostana Linn. suggested that the glycolysis pathway 
may be the major protein target from this extract.
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Comments 
Background
   Though, its clinical application is far from present, the 
present paper has generated a significant contribution of 
the proof of concept, and deeper understanding of using 
mangosteen extract as antimalarial drug target.
  
Research frontiers
   The paper addresses the effect of mangosteen extract on 
malaria glycolysis pathway. Methodology applied is straight 
forward and has yielded appreciable results. The work 
generated scientific idea to bridge between “concept” and 
future “clinical application”.
Innovations and breakthroughs
   The paper concluded that mangosteen affects parasite 
glycolysis pathway. The paper initiates further research 
interest in looking for new antimarial drug target using 
medicinal plants/fruits parts.
  
Applications
    The proteomics approach is a potential tool for target 
identification in the drug discovery. Investigation of possible 
protein targets for antimalarial activity of ethanolic extract of 
G. mangostana Linn. suggested that the glycolysis pathway 
may be the major protein target from this extracts.  
Peer review
   The paper is a basic research which looked at new 
antimalarial target-mangosteen extract and concluded its 
effect through glycolysis pathway. 
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